EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2026 Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2026 Earnings Call Transcript May 6, 2026EyePoint Pharmaceuticals, Inc. misses on earnings expectations.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RWC Asset Management Tord Stallvik (Ceo) | 17,652 | $227,534 | +3% | 0.01% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.15 | 1,500 | $19,723.80 | 100,665 | 2026-03-16 | Filing | |
| $5.99 | 5,000 | $29,950.00 | 36,500 | 2025-05-19 | Filing | |
| $5.81 | 5,000 | $29,050.00 | 31,500 | 2025-05-16 | Filing | |
| $5.47 | 5,000 | $27,350.00 | 26,500 | 2025-05-15 | Filing | |
| $5.42 | 5,000 | $27,100.00 | 21,500 | 2025-05-14 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-04-17 | Filing | |
| $17.87 | 2,438 | $43,571.69 | 0 | 2026-03-04 | Filing | |
| $15.00 | 2,437 | $36,555.00 | 0 | 2026-02-17 | Filing | |
| $17.10 | 42,544 | $727,319.46 | 0 | 2026-01-05 | Filing | |
| $15.70 | 60,000 | $942,240.00 | 8,265,000 | 2025-12-04 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,559,569 | $45,882,844 | 0% | |
| 2. | 1,738,378 | $22,407,692 | 0.04% | |
| 3. | 1,084,857 | $13,983,807 | 5.58% | |
| 4. | 833,455 | $10,743,235 | 0.01% | |
| 5. | 793,870 | $10,232,984 | 0% |